Divergent effect of liver X receptor agonists on prostate‐specific antigen expression is dependent on androgen receptor in prostate carcinoma cells
- 5 January 2015
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 75 (6) , 603-615
Abstract
BACKGROUND: Liver X receptor (LXR) isoforms, LXRα and LXRβ, have similar protein structures and ligands, but diverse tissue distribution. We used two synthetic, non‐steroidal LXR agonists, T0901317 and GW3965, to investigate the effects of LXR agonist modulation on prostate specific antigen (PSA) via the expressions of androgen receptors (AR), LXRα, or LXRβ, in prostate carcinoma cells.METHODS: LXRα‐ or LXRβ‐knockdown cells were transduced with specific shRNA lentiviral particles. LXRα and LXRβ expressions were assessed by immunoblotting and RT‐qPCR assays. Cell proliferation was determined by 3H‐thymidine incorporation assays. The effects of LXR agonists and epigallocatechin gallate (EGCG) on PSA expression were determined by ELISA, immunoblotting, or transient gene expression assays.RESULTS: Treatment with either T0901317 or GW3965 significantly attenuated cell proliferation of LNCaP cells. T0901317 treatment suppressed PSA expression while GW3965 treatment enhanced PSA expression. The increase of PSA promoter activity by GW3965 was dependent on the expression of AR. Either LXRα‐ or LXRβ‐knockdown did not affect the activation of androgen on PSA gene expression. However, as compared with mock knockdown‐LNCaP cells, the LXRα‐knockdown but not the LXRβ‐knockdown attenuated the effects of T0901317 and GW3965 on PSA expressions. The effect of GW3965 on PSA expression was blocked by the addition of EGCG.CONCLUSIONS: Our results indicate that T0901317 and GW3965 have divergent effects on PSA expressions. The effects of LXR agonists on PSA expression are LXRα‐dependent and AR‐dependent. EGCG blocks the inducing effect of GW3965 on PSA expression. Prostate 75: 603–615, 2015.Keywords
Funding Information
- Chang Gung Memorial Hospital (CMRP-G3B1892, -D1D0202, -G3D0312)
- Taiwan Ministry of Science and Technology (MOST 101-2314-B-182A-099-MY3, 102-2320-B-182-003-MY3)
This publication has 39 references indexed in Scilit:
- Liver X receptors, lipids and their reproductive secrets in the maleBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cellsBiochemical and Biophysical Research Communications, 2007
- Modulation of liver X receptor signaling as novel therapy for prostate cancerJournal of Biomedical Science, 2007
- Receptor feasts on sugar and cholesterolNature Medicine, 2007
- Inhibition of Tumor Growth and Progression of LNCaP Prostate Cancer Cells in Athymic Mice by Androgen and Liver X Receptor AgonistCancer Research, 2006
- Antiproliferative Effect of Liver X Receptor Agonists on LNCaP Human Prostate Cancer CellsCancer Research, 2004
- Identification of a Nonsteroidal Liver X Receptor Agonist through Parallel Array Synthesis of Tertiary AminesJournal of Medicinal Chemistry, 2002
- Role of LXRs in control of lipogenesisGenes & Development, 2000
- Ubiquitous Receptor: Structures, Immunocytochemical Localization, and Modulation of Gene Activation by Receptors for Retinoic Acids and Thyroid HormonesaAnnals of the New York Academy of Sciences, 1995
- LXR, a nuclear receptor that defines a distinct retinoid response pathway.Genes & Development, 1995